The role of sublingual sufentanil nanotabs for pain relief

Bibliography

• Ballantyne JC, Carr DB, Chalmers TC, et al. Postoperative patient-controlled analgesia: meta-analyses of initial randomized control trials. J Clin Anesth 1993;5:182-93
   PubMed Web of Science ®Google Scholar
• Hudcova J, McNicol E, Quah C, et al. Patient-controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database Syst Rev 2006;18:CD003348
   Google Scholar
• Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012;116:248-73
   PubMed Web of Science ®Google Scholar
• AAMI/FDA/Center for Drug Evaluation and Research. Infusing patients safely. Summit Meeting held October. 2010. Available from: http://www.aami.org/publications/summits/AAMI_FDA_Summit_Report.pdf
   Google Scholar
• Meissner B, Nelson W, Hicks R, et al. The rate and costs attributable to intravenous patient-controlled analgesia errors. Hosp Pharm 2009;44:312-24
   Google Scholar
• Smith HS. The metabolism of opioid agents and the clinical impact of their active metabolites. Clin J Pain 2011;27:824-38
   PubMed Web of Science ®Google Scholar
• Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med 1995;13:797-802
   PubMedGoogle Scholar
• Sear JW, Hand CW, Moore RA, et al. Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites. Br J Anaesth 1989;62:28-32
   PubMed Web of Science ®Google Scholar
• Smith MT. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000;27:524-8
   PubMed Web of Science ®Google Scholar
• Wright AW, Mather LE, Smith MT. Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci 2001;69:409-20
   PubMed Web of Science ®Google Scholar
• Lötsch J. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage 2005;29(5 Suppl):S90-103. Review
   PubMed Web of Science ®Google Scholar
• Shafer SL, Flood PD. “The pharmacology of opioids”. In: Geriatric anesthesiology. Springer Science; New York: 2007
   Google Scholar
• Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther 2003;74:102-12
   Google Scholar
• Mather LE. Opioids: a pharmacologist’s delight!. Clin Exp Pharmacol Physiol 1995;22:833-6
   PubMed Web of Science ®Google Scholar
• Momeni M, Crucitti M, De Kock M. Patient-controlled analgesia in the Management of postoperative pain. Drugs 2006;66:2321-37. Review
   PubMed Web of Science ®Google Scholar
• Grass JA. Patient-controlled analgesia. Anesth Analg 2005;101(5 Suppl):S44-61; Review
   PubMed Web of Science ®Google Scholar
• Bailey PL, Streisand JB, East KA, et al. Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg 1990;70:8-15
   PubMed Web of Science ®Google Scholar
• Clark NJ, Meuleman T, Liu WS, et al. Comparison of sufentanil-N2O and fentanyl-N2O in patients without cardiac disease undergoing general surgery. Anesthesiology 1987;66:130-5
   PubMed Web of Science ®Google Scholar
• Ved SA, Dubois M, Carron H, et al. Sufentanil and alfentanil pattern of consumption during patient-controlled analgesia: a comparison with morphine. Clin J Pain 1989;5(Suppl 1):S63-70
   PubMedGoogle Scholar
• Gepts E, Shafer SL, Camu F, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995;83:1194-204
   PubMed Web of Science ®Google Scholar
• Hagle ME, Lehr VT, Brubakken K, et al. Respiratory depression in adult patients with intravenous patient-controlled analgesia. Orthop Nurs 2004;23:18-27. quiz 28-9 Review
   PubMedGoogle Scholar
• Schug SA, Torrie JJ. Safety assessment of postoperative pain management by an acute pain service. Pain 1993;55:387-91
   PubMed Web of Science ®Google Scholar
• Sidebotham D, Dijkhuizen MR, Schug SA. The safety and utilization of patient controlled analgesia. J Pain Symptom Manage 1997;14:202-9
   PubMed Web of Science ®Google Scholar
• American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. 5th edition. American pain society; Glenview, IL: 2003. p. 1-73
   Google Scholar
• Package Insert. Ortho-McNeil, Inc. Alza Corp; Raritan, NJ: 2006
   Google Scholar
• Viscusi ER. Patient-controlled drug delivery for acute postoperative pain management: a review of current and emerging technologies. Reg Anesth Pain Med 2008;33:146-58
   PubMed Web of Science ®Google Scholar
• Power I. Fentanyl HCl iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain. Br J Anaesth 2007;98:4-11. Review
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Evaluation of medicines for human use. Questions and answers on the recommendation to suspend the marketing authorization of Ionsys. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500014766.pdf
   Google Scholar
• Rosati J, Gallagher M, Shook B, et al. Evaluation of an oral patient-controlled analgesia device for pain management in oncology inpatients. J Support Oncol 2007;5:443-8
   PubMedGoogle Scholar
• Gan TJ, Palmer PP, Royal M. Optimizing a drug for PCA delivery: the clinical importance of CST1/2 and t1/2ke0. Poster presented at the Annual Meeting of the American Society of Anesthesiologists; 12 October 2013; San Francisco,CA. Available from: http://www.asaabstracts.com/strands/asaabstracts/searchArticle.htm;jsessionid=03A34F636608C7BBBF247FC6A087784C?index=3&highlight=true&highlightcolor=0&bold=true&italic=false
   Google Scholar
• Royal MA, Melson T, Minkowitz H, et al. Sufentanil sublingual microtablet system: duration of action. Poster presented at the 67th Annual Postgraduate Assembly in Anesthesiology; 16 December 2013; New York, NY. Available from: http://www.call4abstracts.com/handouts/nyssa/view.php?nu=NYSSA13L1_1071
   Google Scholar
• Royal MA, Minkowitz H, Ringold FG, et al. Sufentanil sublingual microtablet system: onset of action. Poster presented at the 67th Annual Postgraduate Assembly in Anesthesiology; 15 December 2013; New York, NY. Available from: http://www.call4abstracts.com/handouts/nyssa/view.php?nu=NYSSA13L1_1067
   Google Scholar
• Ringold FG, Minkowitz H, Gan TJ, et al. A randomized, double-blind trial to evaluate the efficacy and safety of the SufentanilNanoTab PCA System/15 mcg plus rescue morphine versus placebo plus rescue morphine in patients with moderate-to-severe pain after open abdominal surgery. Poster presented at the Annual Meeting of the American Society of Anesthesiologists; 15 October 2013; San Francisco, CA. Available from: http://www.asaabstracts.com/strands/asaabstracts/searchArticle.htm;jsessionid=E061C7FE4728B1AD57280EB73B93A342?index=0&highlight=true&highlightcolor=0&bold=true&italic=false
   Google Scholar
• Royal MA, Minkowitz H, Jove M, et al. A randomized, double-blind, placebo-controlled trial of the sufentanil sublingual microtablet system after major orthopedic surgery. Poster presented at the 67th Annual Postgraduate Assembly in Anesthesiology; 15 December 2013; New York, NY. Available from: http://www.call4abstracts.com/handouts/nyssa/view.php?nu=NYSSA13L1_1069
   Google Scholar
• Melson T, Boyer DL, Minkowitz H, et al. SufentanilNanoTab PCA System versus IV-PCA morphine for postoperative pain: a randomized, open-label, active-comparator trial. Poster presented at the Annual Meeting of the American Society of Anesthesiologists; 14 October 2013; San Francisco, CA. Available from: http://www.acelrx.com/technology/publications/zalviso/309%20Poster.pdf
   Google Scholar
• Royal MA, Minkowitz H, Ringold FG, et al. A review of adverse events from the Phase 3 program of the sufentanil sublingual tablet system. Poster presented at the 67th Annual Postgraduate Assembly in Anesthesiology; December 16 2013; New York, NY. Available from: http://www.call4abstracts.com/handouts/nyssa/view.php?nu=NYSSA13L1_1065
   Google Scholar
• Viscusi ER, Reynolds L, Chung F, et al. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA 2004;291:1333-41
   PubMed Web of Science ®Google Scholar
• Inciardi JA, Suratt HL, Kurtz SP, Burke JJ. The diversion of prescription drugs by health care workers in Cincinnati, Ohio [abstract]. Subst Use Misuse 2006;41:255-64
   PubMed Web of Science ®Google Scholar
• Schechter LN, Harshaw Q, Frye CB, et al. Costs associated with intravenous patient-controlled analgesia (IV-PCA) in US hospitals. Value Health 2013;16:A117
   Web of Science ®Google Scholar
• Kumar P, Sunkaraneni S, Sirohi S, et al. Hydromorphone efficacy and treatment protocol impact on tolerance and mu-opioid receptor regulation. Eur J Pharmacol 2008;597:39-45
   PubMed Web of Science ®Google Scholar
• Purdue pharma material safety data sheet (hydromorphone hydrochloride). 2009. Available from: http://www.purduepharma.com/msdss/Dilaudid_1_2_4mg-mL_Injection_MSDS.pdf
   Google Scholar